PubRank

R Duquesnoy

Author PubWeight™ 46.01‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc 1987 3.73
2 IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION. Surg Res Commun 1987 3.46
3 In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs. Transplant Proc 1988 3.15
4 A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. A report from the Multicenter AIDS Cohort Study. Lancet 1990 2.89
5 De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients. Am J Transplant 2011 2.28
6 Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy. Transplant Proc 1991 1.77
7 FK-506 enhances cyclosporine uptake by peripheral blood lymphocytes. Transplant Proc 1987 1.56
8 Large airway inflammation in heart-lung transplant recipients--its significance and prognostic implications. Transplantation 1990 1.51
9 Multivisceral intestinal transplantation: surgical pathology. Pediatr Pathol 1989 1.45
10 Combined liver-kidney transplantation: analysis of patients with preformed lymphocytotoxic antibodies. Transplant Proc 1988 1.38
11 Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin. J Exp Med 1996 1.36
12 Successful sequential liver-kidney transplantation in a patient with performed lymphocytotoxic antibodies. Transplant Proc 1987 1.25
13 The definition of ABO factors in transplantation: relation to other humoral antibody states. Transplant Proc 1987 1.13
14 Biopsy of marginal donor kidneys: correlation of histologic findings with graft dysfunction. Transplantation 2000 1.05
15 C4d deposition in lung allografts is associated with circulating anti-HLA alloantibody. Transpl Immunol 2005 1.00
16 Renal Transplantation in the Presence of a Positive Cytotoxic Antibody. Transplant Proc 1988 0.99
17 Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging. Transplantation 2000 0.95
18 Immunosuppressive effect of cyclosporine metabolites from human bile on alloreactive T cells. Transplant Proc 1988 0.95
19 Isolation and primary cultures of human intrahepatic bile ductular epithelium. In Vitro Cell Dev Biol 1988 0.90
20 HLA alloimmunization and blood requirements in orthotopic liver transplantation. Transplant Proc 1989 0.87
21 Graft atherosclerosis: effects of cellular rejection and human lymphocyte antigen. J Heart Lung Transplant 1992 0.85
22 HLA-DQ1 is associated with clinical response and survival of patients with melanoma who are treated with interleukin-2. Ther Immunol 1995 0.84
23 HLA-class II antigen expression in human heart-lung allografts. Transplantation 1990 0.84
24 Relationship between the diagnosis, preoperative evaluation, and prognosis after orthotopic liver transplantation. Ann Surg 1988 0.83
25 Associations of HLA-A, B, DR antigens with primary disease in cardiac allograft recipients. Am J Cardiol 1988 0.82
26 Multicenter evaluation of the flow cytometry T-cell crossmatch: results from the American Society of Histocompatibility and Immunogenetics-College of American Pathologists proficiency testing program. Transplantation 1997 0.79
27 B-lymphocyte alloantigens and HLA-D determinants in a North American white population. Transplant Proc 1977 0.79
28 HLA susceptibility to BKV infection. Am J Transplant 2006 0.79
29 Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts. Ann Transplant 1997 0.79
30 Primary cultures of human intrahepatic (biliary) epithelial cells. Transplant Proc 1988 0.78
31 High prevalence of HLA-Cw1 and Cw2 antigens in spondylarthritis. Arthritis Rheum 1979 0.76
32 Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction. J Heart Lung Transplant 1997 0.75
33 FK 506 has no short-term effects on endogenous or exogenous myeloid reconstitution in irradiated mice. Transplant Proc 1991 0.75
34 Phenotypic T-cell changes in thoracic transplant recipients immunosuppressed with FK 506. Transplant Proc 1991 0.75
35 Clinical significance of CMV-specific T helper responses in lung transplant recipients. Hum Immunol 1998 0.75
36 Establishment of Primary Cultures of Human Biliary Epithelium and Induction of Class II Major Histocompatibility Complex Antigens by Interferon Gamma. Transplant Proc 1988 0.75
37 Monoclonal versus polyclonal antibody therapy for prophylaxis against rejection after heart transplantation. J Heart Transplant 1990 0.75
38 [Prognosis of hepatic transplantation as a function of biological, immunological and functional preoperative findings]. Acta Gastroenterol Belg 1988 0.75
39 Sterilization of human small intestine allograft biopsies for later immunologic studies. Transplantation 1991 0.75
40 Clinical relevance of in vitro propagation of activated lymphocytes from endomyocardial biopsy samples of pediatric heart transplant recipients. Pediatr Transplant 1998 0.75
41 A functional analysis of hematopoietic growth factor production from class I and class II human alloreactive T cell clones. Int J Cell Cloning 1988 0.75
42 Two types of CMV-specific memory responses in lung transplant recipients. Transplant Proc 1999 0.75
43 Histocompatibility and other rejection risk factors in cardiac transplantation. Transplant Proc 1991 0.75